Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer. - Wikidata - wikimedia - TriplyDB

Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer.

Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer.

http://www.wikidata.org/entity/Q37386179

about

Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells Imaging circulating tumor cells in freely moving awake small animals using a miniaturized intravital microscope Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack Potential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current Evidence Comparison of three different methods for the detection of circulating tumor cells in mice with lung metastasis.The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial.Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients ATP synthase ecto-α-subunit: a novel therapeutic target for breast cancer.Analysis of circulating tumor cells in breast cancer.Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticity Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker.A novel platform for detection of CK+ and CK- CTCs.Potentiated DNA Damage Response in Circulating Breast Tumor Cells Confers Resistance to Chemotherapy.Site-specific DNA-antibody conjugates for specific and sensitive immuno-PCR.Transferrin-bound proteins as potential biomarkers for advanced breast cancer patients.Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis.Progress in using circulating tumor cell information to improve metastatic breast cancer therapy Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer.Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor.Recent advances in the molecular characterization of circulating tumor cells.Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment.Breast cancer biomarker measurements and standards.Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies.Advanced technologies for studying circulating tumor cells at the protein level.Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy.Prognostic value of circulating tumor cells in metastatic breast cancer: a systemic review and meta-analysis.Multispectral Imaging Analysis of Circulating Tumor Cells in Negatively Enriched Peripheral Blood Samples.Circulating tumor cells in breast cancer: applications in personalized medicine.RUNX3 is a prognostic marker and potential therapeutic target in human breast cancer.Cancer. Circulating tumor cells.Predictive Value of Circulating Tumor Cells for Evaluating Short- and Long-Term Efficacy of Chemotherapy for Breast Cancer.Tumor Heterogeneity in Breast Cancer.Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients.HER2 amplification detected in the circulating DNA of patients with gastric cancer: a retrospective pilot study.Ultrasensitive electrochemical immunoassay of proteins based on in situ duple amplification of gold nanoparticle biolabel signals.

P2860

Q26748850-11999AE1-4D1B-4110-862F-921BAC2FB81C Q27329640-3605F53F-AA23-44C5-8F1D-48E40A14FC9E Q28067549-659DCD9E-A36D-49E6-B8F1-390B0BC5421A Q28075850-ED711B97-AEE1-4785-A085-1D9A898CE8EF Q33721117-C542BFCF-9509-49A5-A77D-0D3C73EB7481 Q33769034-CA33DC46-F2F8-43B0-AA21-E9C4EC127203 Q33820233-F7E9F50E-7F71-49F5-82BF-9E2E46DD5D27 Q33839150-90884A1E-B31D-496B-9B99-D072CB85A8F8 Q34094912-4BA8A857-F5A9-4567-8381-CED0F595C8E0 Q34156275-270E5563-52E9-4FAB-9278-DB73F53117A6 Q34558889-662753E9-55CC-4497-A7AF-2D3F5BE0623F Q34571624-45D9135B-FE72-4D14-94DB-77F8D7D6D8EA Q35124176-339D5C0D-2241-470F-ADE3-D65E53C2C041 Q35519793-1AF0E327-CFF1-48B0-9F28-92313738A1F4 Q35612329-38BDFAB4-A5C1-42FA-BA66-D1E554497073 Q35721595-47FD5110-2F2B-4C0A-8066-58531D7C9BA7 Q35844968-1D7915DD-D649-4029-B433-A65FAFA63030 Q36250711-9A589ED5-1E6D-491E-B7B1-46CEDDBC982D Q36321612-1A5E2728-9C93-4E58-A6FB-7D45AEC02ED0 Q36752761-5BAB5491-7B66-47C8-BD37-0F92BB10FC50 Q36804888-9F8FA08F-4396-4CDE-8573-5C6BAD7D2D95 Q37352090-65E4B39D-1E4B-4517-A57A-E3846E3A28E6 Q37693504-8E3AEEF6-A385-4148-A52F-D7CBBA2C14C6 Q38018253-7E6C3E90-0553-4F45-BF2C-20C1C8B253E1 Q38076082-CE6D998B-ACBB-4043-B3B6-7950D4B4A1FB Q38097525-25A70C9B-E3A0-4E04-993E-CEF80CE83825 Q38160932-736206A2-956C-489E-94CD-670AD2D0D94B Q38547813-9ED6A5BC-DE00-4A1A-9ABC-00454B92A339 Q38564112-39A3BE99-8B44-457B-B1BD-DC18E74AD61E Q38640450-6A51BE4D-5009-4B74-8126-9CE5CB1223D8 Q38985771-0ACA3493-52EA-4D71-B95A-5DD292369BA1 Q39100545-41863D43-252E-4C65-B4CB-3A25D3EA0C38 Q41841820-7F6A290A-D8FE-4F1C-B1EC-F0EF44CC1570 Q42378538-81B1CAB7-3438-48BE-BD80-EE26F5A1886A Q47146956-CBBDB5A9-1CA4-43B3-BBC1-9CD5E8962E98 Q50642054-B4005130-5332-49F3-84DF-9EB2EF07156F Q53010792-8421B1D8-F45E-4457-A0E2-491B0C9815B6 Q53257680-FA564995-1A51-4EBD-966B-D23B5BA55353

P2860

Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer.

http://www.wikidata.org/entity/Q37386179

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 June 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prognostic value of HER2-posit ...... with metastatic breast cancer.

@en

Prognostic value of HER2-posit ...... with metastatic breast cancer.

@nl

type

label

Prognostic value of HER2-posit ...... with metastatic breast cancer.

@en

Prognostic value of HER2-posit ...... with metastatic breast cancer.

@nl

prefLabel

Prognostic value of HER2-posit ...... with metastatic breast cancer.

@en

Prognostic value of HER2-posit ...... with metastatic breast cancer.

@nl

P1433

Q37386179-183B7465-9800-464A-94A3-2DE67EDB99D4

P1476

Q37386179-E7AF2460-A8C6-4734-BCF2-DB1E9A8DB69E

P2093

Q37386179-04EDD0EB-2DFA-4055-8583-07A097AE9008

Q37386179-1962081D-45F4-4D38-8D2D-29493CF06C8D

Q37386179-80F5314E-4ECA-4B59-BEBB-489F6E8C44FC

Q37386179-9B91A15D-7D02-496C-9DA6-C2507B79A4C9

Q37386179-A296A85D-64B7-4B99-9CDB-D76FCF2DB3FF

Q37386179-B822C251-C75E-4F7A-AD90-423CFDE10DA7

Q37386179-BC5EE673-924A-4AF1-A1C2-CF399E9A4ACB

Q37386179-BEF9AE32-CD81-42EC-8B38-0157F898C293

Q37386179-DC2E8575-37F3-4BEE-B3BA-0C65B9AF83FD

P2860

Q37386179-11ACE19C-A3DC-46F0-90A2-41F3853253AE

Q37386179-13B02E8D-AF02-4D67-8465-6B86091C0180

Q37386179-38DEA6DD-5234-4681-BAFF-93196657EC14

Q37386179-3CEFC33C-9D7E-4285-A313-E181184B648E

Q37386179-4179DC31-76C0-4727-8CB8-175E83C86D61

Q37386179-4784BDBD-155C-477F-9671-77BA263B1421

Q37386179-5018A181-91E3-4900-8C95-A0DA868F7AF5

Q37386179-548EB7FB-A470-4B37-B751-4C4EBEFCCA0F

Q37386179-66DED4C1-6ED0-4950-9EA1-D7062D0070E2

Q37386179-72B8751A-86E8-42CE-BDA1-71E03D125C8A

P2888

Q37386179-17E70C74-02A2-42B7-9E3D-15A683AF4F0C

P304

Q37386179-F44C959B-4DAE-4E4D-A413-DEA459ABE684

P31

Q37386179-A350DA8D-69B7-4D05-BD08-496C7860535D

P356

Q37386179-235BE14C-8AE8-4A72-ACDD-49E9F3BF60FB

P433

Q37386179-31B0A481-2938-4A2E-BCEE-D3CF9E51C2D2

P478

Q37386179-6D1C3C9B-5B14-4F56-8579-F59B183835FC

P50

Q37386179-398CEDB5-C84D-452E-8E89-C1945B2FFE2C

P577

Q37386179-DC5A75D3-0B5B-4E74-880A-0C65C6FED54F

P698

Q37386179-EF463C1B-39E3-4928-B908-47C08B4FDE8D

P921

Q37386179-B28911FA-C75C-416F-891B-D2DD6A3A8FFA

P932

Q37386179-779CBE81-046A-4C0A-83E5-FB26F8595442

P356

S10147-011-0260-0

P1433

International Journal of Clinical Oncology

P1476

Prognostic value of HER2-posit ...... with metastatic breast cancer

@en

P2093

Gabriel N Hortobagyi

http://www.w3.org/2001/XMLSchema#string

Hidekazu Ota

http://www.w3.org/2001/XMLSchema#string

Hiroshi Yagata

http://www.w3.org/2001/XMLSchema#string

Massimo Cristofanilli

http://www.w3.org/2001/XMLSchema#string

Naoki Hayashi

http://www.w3.org/2001/XMLSchema#string

Naoto T Ueno

http://www.w3.org/2001/XMLSchema#string

Seigo Nakamura

http://www.w3.org/2001/XMLSchema#string

Yasuharu Tokuda

http://www.w3.org/2001/XMLSchema#string

Yuji Shimoda

http://www.w3.org/2001/XMLSchema#string

P2860

HER-2 gene amplification can be acquired as breast cancer progresses

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Cancer statistics, 2009

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment.

Tumour marker measurements in the diagnosis and monitoring of breast cancer.

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.

Detection of Her2/neu, c-MYC and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization.

Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.

Serum tumor markers in breast cancer: are they of clinical value?

P2888

s10147-011-0260-0

P304

96-104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10147-011-0260-0

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Atsushi Yoshida

P577

2011-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21671160

http://www.w3.org/2001/XMLSchema#string

P921

P932

3860324

http://www.w3.org/2001/XMLSchema#string